Skip to main content

ADVERTISEMENT

John A. Phillips, MD, FACC, FSCAI, RPVI

Case Report
11/03/2023
This case report aims to shed light on the potential utilization of renal artery stents within aneurysmal coronary vessels to provide patients with ACAD first-line intervention in the setting of acute coronary syndrome.
This case report aims to shed light on the potential utilization of renal artery stents within aneurysmal coronary vessels to provide patients with ACAD first-line intervention in the setting of acute coronary syndrome.
This case report aims to shed...
11/03/2023
Cath Lab Digest
John A. Phillips, MD
TACK ENDOVASCULAR REPAIR
06/26/2022
A presentation by John A. Phillips, MD, FACC, FSCAI, System Director, OhioHealth Vascular Institute.
A presentation by John A. Phillips, MD, FACC, FSCAI, System Director, OhioHealth Vascular Institute.
A presentation by John A....
06/26/2022
Cath Lab Digest
09/05/2019
I probably have 10-12 tibial cases under my belt. According to Corindus, in November 2018, we did the first tibial chronic total occlusion (CTO) with the system.
I probably have 10-12 tibial cases under my belt. According to Corindus, in November 2018, we did the first tibial chronic total occlusion (CTO) with the system.
I probably have 10-12 tibial...
09/05/2019
Cath Lab Digest
Lower-Extremity Intervention
10/09/2021
We now have the technology to get through the lesion, treat it with effective devices, and be more efficient. We can also bear that fiduciary responsibility with greater ease, because the 300mm Lutonix™ (BD) allows us to use a single balloon...
We now have the technology to get through the lesion, treat it with effective devices, and be more efficient. We can also bear that fiduciary responsibility with greater ease, because the 300mm Lutonix™ (BD) allows us to use a single balloon...
We now have the technology to...
10/09/2021
Cath Lab Digest
Editor's Corner
02/09/2018
The authors evaluated their 1- and 2-year patency rates as well as the clinically driven reintervention rates in their patients with diffuse de novo and instent restenotic FP atherosclerotic lesions greater than 20 cm who received the Zilver...
The authors evaluated their 1- and 2-year patency rates as well as the clinically driven reintervention rates in their patients with diffuse de novo and instent restenotic FP atherosclerotic lesions greater than 20 cm who received the Zilver...
The authors evaluated their 1-...
02/09/2018
Vascular Disease Management
Case Report
09/16/2019
This report describes the use of the CorPath GRX Robotic System to improve the safety of the interventionalist during percutaneous balloon angioplasty of an occluded posterior tibial artery.
This report describes the use of the CorPath GRX Robotic System to improve the safety of the interventionalist during percutaneous balloon angioplasty of an occluded posterior tibial artery.
This report describes the use of...
09/16/2019
Vascular Disease Management